Literature DB >> 21544522

West nile virus neuroinvasive disease.

Roberta L Debiasi1.   

Abstract

West Nile virus (WNV), first recognized in North America in 1999, was responsible for the largest arboviral epidemic of human encephalitis in history and continues to be the most frequent cause of epidemic meningoencephalitis in North America. WNV neuroinvasive disease (WNND) occurs in fewer than 1% of infected individuals, with presentations including aseptic meningitis, encephalitis, and poliomyelitis. Between 1999 and 2009, over 12,000 cases of WNND were reported in the United States, with the peak annual incidence occurring in epidemics of 2002 and 2003. In this review, we first summarize the epidemiology of WNV over the past decade and the salient clinical features of WNND, including a discussion of laboratory and radiographic findings, risk factors, morbidity, and mortality. In addition, we review recent progress in our understanding of virus and host determinants of the pathogenesis of WNND, as well as the prospects for the development of specific therapeutic targets.

Entities:  

Year:  2011        PMID: 21544522     DOI: 10.1007/s11908-011-0193-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  71 in total

Review 1.  West Nile virus disease in children.

Authors:  Edward B Hayes
Journal:  Pediatr Infect Dis J       Date:  2006-11       Impact factor: 2.129

2.  A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.

Authors:  Jason A Wicker; Melissa C Whiteman; David W C Beasley; C Todd Davis; Shuliu Zhang; Bradley S Schneider; Stephen Higgs; Richard M Kinney; Alan D T Barrett
Journal:  Virology       Date:  2006-04-19       Impact factor: 3.616

3.  Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice.

Authors:  Huafang Lai; Michael Engle; Anja Fuchs; Thomas Keller; Syd Johnson; Sergey Gorlatov; Michael S Diamond; Qiang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

4.  Use of RNA interference to prevent lethal murine west nile virus infection.

Authors:  Fengwei Bai; Tian Wang; Utpal Pal; Fukai Bao; L Hannah Gould; Erol Fikrig
Journal:  J Infect Dis       Date:  2005-02-23       Impact factor: 5.226

Review 5.  Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features.

Authors:  B K Kleinschmidt-DeMasters; Brad A Marder; Marilyn E Levi; Stephen P Laird; J Trevor McNutt; Edward J Escott; Gregory T Everson; Kenneth L Tyler
Journal:  Arch Neurol       Date:  2004-08

6.  Clinical characteristics and functional outcomes of West Nile Fever.

Authors:  John T Watson; Peter E Pertel; Roderick C Jones; Alicia M Siston; William S Paul; Constance C Austin; Susan I Gerber
Journal:  Ann Intern Med       Date:  2004-09-07       Impact factor: 25.391

7.  West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons.

Authors:  John D Morrey; Venkatraman Siddharthan; Hong Wang; Jeffery O Hall; Ramona T Skirpstunas; Aaron L Olsen; Jeffrey L Nordstrom; Scott Koenig; Syd Johnson; Michael S Diamond
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

8.  Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic.

Authors:  Beth K Schweitzer; Wayne L Kramer; Anthony R Sambol; Jane L Meza; Steven H Hinrichs; Peter C Iwen
Journal:  Clin Vaccine Immunol       Date:  2006-03

9.  Increase in West Nile neuroinvasive disease after Hurricane Katrina.

Authors:  Kevin A Caillouët; Sarah R Michaels; Xu Xiong; Ivo Foppa; Dawn M Wesson
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

10.  A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes.

Authors:  Bruce S Thompson; Bastiaan Moesker; Jolanda M Smit; Jan Wilschut; Michael S Diamond; Daved H Fremont
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  12 in total

Review 1.  The role of chemokines in the pathogenesis of neurotropic flaviviruses.

Authors:  Susana V Bardina; Jean K Lim
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

2.  West nile virus.

Authors:  Georg Pauli; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-07-04       Impact factor: 3.747

3.  A brief report of West Nile Virus neuroinvasive disease in the summer of 2012 in Hamilton, Ontario.

Authors:  Lei Jiao; Cheryl Main
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

Review 4.  West Nile virus state of the art report of MALWEST Project.

Authors:  Andriani Marka; Alexandros Diamantidis; Anna Papa; George Valiakos; Serafeim C Chaintoutis; Dimitrios Doukas; Persefoni Tserkezou; Alexios Giannakopoulos; Konstantinos Papaspyropoulos; Eleni Patsoula; Evangelos Badieritakis; Agoritsa Baka; Maria Tseroni; Danai Pervanidou; Nikos T Papadopoulos; George Koliopoulos; Dimitrios Tontis; Chrysostomos I Dovas; Charalambos Billinis; Athanassios Tsakris; Jenny Kremastinou; Christos Hadjichristodoulou; Nikolaos Vakalis; Evdokia Vassalou; Spyridoula Zarzani; Athanassios Zounos; Katerina Komata; Georgios Balatsos; Stavroula Beleri; Anastasia Mpimpa; Vasilios Papavasilopoulos; Ioannis Rodis; Grigorios Spanakos; Nikolaos Tegos; Vasiliki Spyrou; Zisis Dalabiras; Periklis Birtsas; Labrini Athanasiou; Maria Papanastassopoulou; Charalambos Ioannou; Christos Athanasiou; Christos Gerofotis; Elpida Papadopoulou; Theodolinta Testa; Ourania Tsakalidou; George Rachiotis; Nikolaos Bitsolas; Zissis Mamouris; Katerina Moutou; Theologia Sarafidou; Konstantinos Stamatis; Konstantina Sarri; Sotirios Tsiodras; Theano Georgakopoulou; Marios Detsis; Maria Mavrouli; Anastasia Stavropoulou; Lida Politi; Georgia Mageira; Varvara Christopoulou; Georgia Diamantopoulou; Nikolaos Spanakis; Georgia Vrioni; Evangelia-Theofano Piperaki; Kornilia Mitsopoulou; Ilias Kioulos; Antonios Michaelakis; Ioannis Stathis; Ioannis Tselentis; Anna Psaroulaki; Maria Keramarou; Dimosthenis Chochlakis; Yeorgios Photis; Maria Konstantinou; Panagiotis Manetos; Stylianos Tsobanoglou; Spyros Mourelatos; Vasilis Antalis; Panagiotis Pergantas; Georgios Eleftheriou
Journal:  Int J Environ Res Public Health       Date:  2013-12-02       Impact factor: 3.390

5.  West Nile Neuroinvasive Disease With Atypical CSF Findings: A Case Report.

Authors:  Devin Simon
Journal:  Neurohospitalist       Date:  2021-02-15

6.  Altered mental status and fever.

Authors:  Tokunbo Ajayi; Ashmeet Bhatia; Barbara Lambl; Sarah Altamimi
Journal:  BMJ Case Rep       Date:  2013-06-24

7.  Assurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine.

Authors:  Olga A Maximova; James M Speicher; Jeff R Skinner; Brian R Murphy; Marisa C St Claire; Danny R Ragland; Richard L Herbert; Dan R Pare; Rashida M Moore; Alexander G Pletnev
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

Review 8.  Mechanism of West Nile virus neuroinvasion: a critical appraisal.

Authors:  Willy W Suen; Natalie A Prow; Roy A Hall; Helle Bielefeldt-Ohmann
Journal:  Viruses       Date:  2014-07-18       Impact factor: 5.048

9.  Two case reports of neuroinvasive west nile virus infection in the critical care unit.

Authors:  Edgardo M Flores Anticona; Hadeel Zainah; Daniel R Ouellette; Laura E Johnson
Journal:  Case Rep Infect Dis       Date:  2012-08-27

10.  Emergence of human West Nile Virus infection in Sri Lanka.

Authors:  Janarthani Lohitharajah; Gathsaurie Neelika Malavige; Anthony Jin Shun Chua; Mah Lee Ng; Carukshi Arambepola; Thashi Chang
Journal:  BMC Infect Dis       Date:  2015-07-31       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.